Portal de Periódicos da CAPES

Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features

2004; Oxford University Press; Volume: 150; Issue: 6 Linguagem: Inglês

10.1111/j.1365-2133.2004.05928.x

1365-2133

Maria Antonietta Pizzichetta, Renato Talamini, Ignazio Stanganelli, Pietro Puddu, R. Bono, Giuseppe Argenziano, Andrea Veronesi, Giusto Trevisan, Harold Rabinovitz, H. Peter Soyer,

Cutaneous lymphoproliferative disorders research

Journal Article Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features Get access M.A. Pizzichetta, M.A. Pizzichetta Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Maria Antonietta Pizzichetta. E‐mail: pizzichetta@cro.it Search for other works by this author on: Oxford Academic Google Scholar R. Talamini, R. Talamini Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar I. Stanganelli, I. Stanganelli Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar P. Puddu, P. Puddu Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar R. Bono, R. Bono Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar G. Argenziano, G. Argenziano Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar A. Veronesi, A. Veronesi Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar G. Trevisan, G. Trevisan Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar H. Rabinovitz, H. Rabinovitz Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar H.P. Soyer H.P. Soyer Division of Medical Oncology C–Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Via Pedemontana Occidentale 12, I‐33081 Aviano, Italy *Epidemiology Unit, Centro di Riferimento Oncologico, Aviano, Italy †Skin Cancer Unit, Ravenna–Niguarda Hospital, Milano, Italy ‡Department of Onco‐Immunodermatology, IDI, Rome, Italy §Department of Dermatology, Second University of Naples, Italy ¶Department of Dermatology, University of Trieste, Italy **Department of Dermatology, University of Miami, USA ††Department of Dermatology, University of Graz, Austria Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 150, Issue 6, 1 June 2004, Pages 1117–1124, https://doi.org/10.1111/j.1365-2133.2004.05928.x Published: 01 June 2004 Article history Accepted: 05 November 2003 Published: 01 June 2004